Medications

India's patent laws under pressure: The Lancet special report

In a special report in The Lancet, researchers from Queen Mary, University of London (UK) argue that pending cases against India's patent laws threaten public health and misinterpret international intellectual property agreements.

Medications

Novartis, Amgen partner on Alzheimer's, migraine treatment

Swiss drug maker Novartis says it will cooperate with California-based biotech giant Amgen to develop and sell neuroscience treatments for illnesses and ailments like Alzheimer's disease and migraine headaches.

Medications

US panel sees risk in long-used osteoporosis drug

A panel of U.S. government health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer.

Medications

Italy lifts ban on Novartis flu vaccines

Italian health authorities on Friday lifted a ban on the sale of flu vaccines made by Swiss pharmaceutical giant Novartis, saying that tests had shown they were not a health risk.

Medications

Japan to seek criminal prosecution of Novartis

Japan's health ministry intends to file a criminal complaint against the local arm of Swiss pharmaceutical giant Novartis over alleged fabrication of drugs data, a report said Wednesday.

page 11 from 16